FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2010358244> ?p ?o ?g. }

• W2010358244 endingPage "17102" @default.
• W2010358244 startingPage "17098" @default.
• W2010358244 abstract "The pathological correlates of dementia due to human immunodeficiency virus (HIV) infection are glial cell activation and cytokine dysregulation. These findings occur in the setting of small numbers of productively infected cells within the brain. We determined whether exposure of susceptible cells to Tat protein of HIV could result in the production of select proinflammatory cytokines. In a dose-responsive manner, Tat induced interleukin (IL)-1β production in monocytic cells, while astrocytic cells showed an increase in mRNA for IL-1β, but had a translation block for IL-1β protein production. Conversely, IL-6 protein and mRNA productions were strongly induced in astrocytic cells and minimally in monocytic cells. IL-1β and IL-6 production were independent of tumor necrosis factor-α production. An exposure to Tat for a few minutes was sufficient for sustained releases of cytokines for several hours. This prolonged cytokine production is likely maintained by a positive feed back loop of Tat-induced nuclear factor κB activation and cytokine production that is independent of extracellular calcium. Thus a transient exposure may be sufficient to initiate a cascade of events resulting in cerebral dysfunction and a “hit and run” approach may be in effect. Hence cross-sectional measurement of viral load in the brain may not be a useful indicator of the role of viral products in the neuropathogenesis of HIV dementia. The pathological correlates of dementia due to human immunodeficiency virus (HIV) infection are glial cell activation and cytokine dysregulation. These findings occur in the setting of small numbers of productively infected cells within the brain. We determined whether exposure of susceptible cells to Tat protein of HIV could result in the production of select proinflammatory cytokines. In a dose-responsive manner, Tat induced interleukin (IL)-1β production in monocytic cells, while astrocytic cells showed an increase in mRNA for IL-1β, but had a translation block for IL-1β protein production. Conversely, IL-6 protein and mRNA productions were strongly induced in astrocytic cells and minimally in monocytic cells. IL-1β and IL-6 production were independent of tumor necrosis factor-α production. An exposure to Tat for a few minutes was sufficient for sustained releases of cytokines for several hours. This prolonged cytokine production is likely maintained by a positive feed back loop of Tat-induced nuclear factor κB activation and cytokine production that is independent of extracellular calcium. Thus a transient exposure may be sufficient to initiate a cascade of events resulting in cerebral dysfunction and a “hit and run” approach may be in effect. Hence cross-sectional measurement of viral load in the brain may not be a useful indicator of the role of viral products in the neuropathogenesis of HIV dementia. The pathogenesis of dementia associated with HIV 1The abbreviations used are: HIV, human immunodeficiency virus; ELISA, enzyme-linked immunosorbent assay; RT, reverse transcriptase; PCR, polymerase chain reaction; IL, interleukin; TLCK, N-α-tosyl-l-lysine chloromethyl ketone; TNF-α, tumor necrosis factor-α; PBS, phosphate-buffered saline; BAPTA, 1,2-bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid; NFκB, nuclear factor κB infection involves the complex interactions of viral products and cytokines, which eventually result in neuronal dysfunction and cell loss. Several studies have shown that viral proteins such as Tat and gp120 can induce cytokine dysregulation in macrophages and glial cells as well as cause neurotoxicity (1Nath A. Geiger J.D. Prog. Neurobiol. 1998; 54: 19-33Crossref PubMed Scopus (215) Google Scholar). However, it remains uncertain as to why infection of the brain is limited in comparison with the severity of the clinical presentation. In fact, macrophage infiltration, glial cell activation and not viral load in the brain seem to correlate best with the severity of dementia (2Glass J.D. Wesselingh S.L. Selnes O.A. McArthur J.C. Neurology. 1993; 43: 2230-2237Crossref PubMed Google Scholar, 3Johnson R.T. Glass J.D. McArthur J.C. Chesebro B.W. Ann. Neurol. 1996; 39: 392-395Crossref PubMed Scopus (106) Google Scholar). In keeping with these observations cytokine levels in brain and cerebrospinal fluid are elevated in patients with HIV dementia (2Glass J.D. Wesselingh S.L. Selnes O.A. McArthur J.C. Neurology. 1993; 43: 2230-2237Crossref PubMed Google Scholar, 4Merrill J.E. Chen I.S.Y. FASEB J. 1991; 5: 2391-2397Crossref PubMed Scopus (339) Google Scholar). The Tat protein of HIV is of particular interest, since it is released extracellularly from unruptured, HIV-infected lymphoid and microglial cells (5Ensoli B. Buonaguro L. Barillari G. Fiorelli V. Gendelman R. Morgan R. Wingfield P. Gallo R. J. Virol. 1993; 67: 277-287Crossref PubMed Google Scholar, 6Tardieu M. Hery C. Peudenier S. Boespflug O. Montagnier L. Ann. Neurol. 1992; 32: 11-17Crossref PubMed Scopus (137) Google Scholar). Tat exits from cells via a leaderless secretory pathway in the absence of permeability changes (7Chang H.C. Samaniego F. Nair B.C. Buonaguro L. Ensoli B. AIDS. 1997; 11: 1421-1431Crossref PubMed Scopus (393) Google Scholar). This protein thus has the opportunity to interact with other uninfected cells. Further Tat can be detected in mononuclear cells within the brain of patients with HIV encephalitis (8Hofman F.M. Dohadwala M.M. Wright A.D. Hinton D.R. Walker S.M. J. Neuroimmunol. 1994; 54: 19-28Abstract Full Text PDF PubMed Scopus (92) Google Scholar) and in the sera of HIV-infected individuals (9Westendorp M.O. Frank R. Ochsenbauer C. Stricker K. Dhein J. Walczak H. Debatin K.-M. Krammer P.H. Nature. 1995; 375: 497-500Crossref PubMed Scopus (916) Google Scholar). Tat-mRNA levels are also elevated in the brains of patients with HIV dementia (10Wesselingh S.L. Power C. Glass J.D. Tyor W.R. McArthur J.C. Farber J.M. Griffin J.W. Griffin D.E. Ann. Neurol. 1993; 33: 576-582Crossref PubMed Scopus (403) Google Scholar, 11Wiley C.A. Baldwin M. Achim C.L. AIDS. 1996; 10: 943-947Crossref Scopus (119) Google Scholar). It has been shown previously that the Tat protein of HIV can induce macrophage infiltration in the brain (12Jones M. Olafson K. Del Bigio M.R. Peeling J. Nath A. J. Neuropathol. Exp. Neurol. 1998; 57: 563-570Crossref PubMed Scopus (143) Google Scholar) likely via production of monocyte chemoattractant protein-1 by astrocytes (13Conant K. Garzino-Demo A. Nath A. McArthur J.C. Halliday W. Power C. Gallo R.C. Major E.O. Proc. Natl. Acad. Sci. U. S. A. 1998; 95: 3117-3121Crossref PubMed Scopus (506) Google Scholar). Tat also causes glial cell activation for several days post intracerebroventricular inoculation (12Jones M. Olafson K. Del Bigio M.R. Peeling J. Nath A. J. Neuropathol. Exp. Neurol. 1998; 57: 563-570Crossref PubMed Scopus (143) Google Scholar). Furthermore, a Tat-derived peptide when injected into the brain causes cytokine dysregulation (14Philippon V. Vellutini C. Gambarelli D. Harkiss G. Arbuthnott G. Metzger D. Roubin R. Filippi P. Virology. 1994; 205: 519-529Crossref PubMed Scopus (133) Google Scholar) similar to that observed in patients with HIV infection (10Wesselingh S.L. Power C. Glass J.D. Tyor W.R. McArthur J.C. Farber J.M. Griffin J.W. Griffin D.E. Ann. Neurol. 1993; 33: 576-582Crossref PubMed Scopus (403) Google Scholar, 15Vitkovic L. Geretta W.P. Major E.O. Fauci A.S. AIDS Res. Hum. Retroviruses. 1991; 7: 723-727Crossref PubMed Scopus (33) Google Scholar). In this study, we examine the possibility that a transient exposure of cells to Tat may be sufficient to induce a sustained production of cytokines and we determine the role of extracellular calcium and autoregulation in cytokine production. Peripheral blood monocytes were isolated by a Percoll gradient technique, and human fetal astrocyte cultures were prepared by differential adhesion as described previously (16Furer M. Hartloper V. Wilkins J. Nath A. Cell Adhes. Commun. 1993; 1: 223-237Crossref PubMed Scopus (21) Google Scholar). The human astrocytoma cell line U373 and monocytic cell line THP-1 were obtained from American Type Culture Collection (Rockville, MD). Human astrocytes and U373 cells were maintained in minimal essential medium with heat-inactivated 10% (v/v) fetal bovine serum and 1 mm sodium pyruvate. Monocytes were cultured in RPMI with 10% fetal bovine serum. All cell types were supplemented with 100 μg of streptomycin/ml and 0.25 μg amphotericin/ml. THP-1 cells were cultured in RPMI medium with 10% fetal bovine serum and 5.5 μm β-mercaptoethanol. The cells were cultured to approximately 95% confluence in 24-well plates (≈1 × 105 cells/ml). Highly purified (>95%) recombinant Tat protein was prepared from the tat gene encoding the first 72 amino acids as outlined previously (17Ma M. Nath A. J. Virol. 1997; 71: 2495-2499Crossref PubMed Google Scholar). The functional properties of this protein were confirmed using a transactivation assay in HL3T1 cells containing the HIV-1 long terminal repeat, chloramphenicol acetyltransferase construct (17Ma M. Nath A. J. Virol. 1997; 71: 2495-2499Crossref PubMed Google Scholar). For experiments designed to determine the effect of a transient exposure to Tat, cells were treated with 100 ng/ml Tat for either 5, 30, or 60 min, following which the cells were washed five times and then reincubated in culture media without Tat protein. In each case, culture supernatants were collected at 30, 90, and 180 min following reincubation without Tat and analyzed for the presence of IL-1β, IL-6, and TNF-α. For experiments designed to determine the role of TNF-α in IL-1 and IL-6 production, the monocytes and astrocytes were preincubated with antisera to TNF-α (0.5 μg/ml; R&D Systems) for 30 min followed by incubation with 100 ng/ml Tat for either 5, 30, or 60 min. The cells were then washed and reincubated with culture media containing antisera to TNF-α. Culture supernatants were then analyzed after another 90 and 180 min for the presence of IL-1, IL-6, or TNF-α. Cells from two different donors were analyzed in triplicates. Data from a representative experiment are shown. To establish dose profiles for each cell type, Tat was used at 0, 10, 100, and 1000 ng/ml concentrations for 4 h with THP-1 cells for IL-1β and IL-6 mRNA detection in THP-1 cells and for 6 h with U373 cells. IL-1β and IL-6 proteins were analyzed in culture supernatants, 16 h post-Tat treatment. Since IL-1β could not be detected in cell culture supernatants of U373 cells, cell extracts of U373 cells were also measured at 1, 3, 6, 12, 24, and 48 h following treatment with 1 μg/ml Tat for IL-1β by ELISA. Cells were stimulated with lipopolysaccharide from Escherichia colitype 055:B5 (Sigma) 1.0 μg/ml as positive controls. Negative controls included mock (PBS)-treated cells and cells that were treated with solutions from which Tat had been immunoadsorbed as described previously (18Chen P. Mayne M. Power C. Nath A. J. Biol. Chem. 1997; 272: 22385-22388Abstract Full Text Full Text PDF PubMed Scopus (202) Google Scholar). Cell culture supernatants were analyzed for IL-1β, IL-6, or TNF-α. Additionally, cell extracts of U373 cells were analyzed for IL-1β. In each case, ELISA kits were used from R&D systems, and the procedure was followed as per the manufacturer's instructions. Briefly, 200 μl of standard or sample was added to each well, which had been precoated with a murine monoclonal antibody (2 μg/ml) against the appropriate cytokine. Following a 2-h incubation with the test sample and three washes, 200 μl of a rabbit polyclonal antibody (diluted 1:1000) directed against the appropriate cytokine was added. One hour later, the plates were washed, color developed, and analyzed using a microtiter plate reader. A standard curve was generated on each microtiter plate, which was used for quantitating the amount of cytokine in each sample. The sensitivity of detection for IL-1β was 4 pg/ml, while that of IL-6 and TNF-α was 5 pg/ml. First strand cDNA was prepared from total cellular RNA as per the manufacturer's protocol (Amersham Pharmacia Biotech). PCR was conducted using published primers for IL-1β, IL-6, and β-actin (19Yamamura M. Uyemura K. Deans R.J. Weinberg K. Rea T.H. Bloom B.R. Modlin R.L. Science. 1991; 254: 277-279Crossref PubMed Scopus (1065) Google Scholar). β-Actin primers served as internal controls in each reaction. PCR products were resolved in a 1.5% agarose gel and transferred to a nylon membrane and probed with [32P]ATP end-labeled oligonucleotide probes. IL-β, IL-6, and β-actin oligonucleotide probes were designed based on products amplified using the above primers (IL-1β, 5′-CTG CAC GCT CCG GGA CTC ACA CCA)-3′; IL-6, 5′AAT CGG GTA CAT CCT CGA CGG CAT CT-3′; β-actin, 5′-GAG ACC TTC AAC ACC CCA GCC ATG T-3′). U373 or THP-1 cells were washed in PBS, treated with EGTA (0.5 mm) or BAPTA (200 μm) for 10 min, followed by incubation with 100 ng/ml Tat in a calcium-free buffer for 1 h. Alternatively, the cells were pretreated with 100 μm TLCK (Sigma) for 30 min followed by treatment with 100 ng/ml Tat for 6 h in serum-containing medium. mRNA expression in each case was analyzed by RT-PCR and Southern blot analysis. To determine the effect of a transient exposure of Tat on cytokine production, we treated monocytes and astrocytes with concentrations of Tat (100 ng/ml) previously shown to induce cytokine production in these cells (18Chen P. Mayne M. Power C. Nath A. J. Biol. Chem. 1997; 272: 22385-22388Abstract Full Text Full Text PDF PubMed Scopus (202) Google Scholar, 20Rautonen N. Rautonen J. Martin N.L. Wara D.W. AIDS. 1994; 8: 1504-1506Crossref PubMed Scopus (24) Google Scholar, 21New D.R. Maggirwar S.B. Epstein L.G. Dewhurst S. Gelbard H.A. J. Biol. Chem. 1998; 273: 17852-17858Abstract Full Text Full Text PDF PubMed Scopus (160) Google Scholar, 22Lafrenie R.M. Wahl L.M. Epstein J.S. Yamada K.M. Dhawan S. J. Immunol. 1997; 159: 4077-4083PubMed Google Scholar). We found that a 5-min exposure to Tat was sufficient to induce maximal amounts of proinflammatory cytokines IL-1β, IL-6, or TNF-α in the monocytes (Fig.1, A–C) and IL-6 in the astrocytes (Fig. 1 D). IL-1β or TNF-α could not be detected in the astrocyte culture supernatants at all time points tested. To determine whether the IL-1β or IL-6 production in these cells was regulated via TNF-α, we analyzed the ability of TNF antisera to inhibit IL-1β or IL-6 production. IL-1β and IL-6 induction by Tat was independent of TNF-α production (Fig. 1,A, B, and D). Even though we used highly purified cultures of monocytes and astrocytes, we could not exclude the possibility of small amounts of other contaminating cell types in these cultures. Hence we used a human monocytoid (THP-1) and astrocytic (U373) cells for further experiments. We have previously characterized Tat-induced TNF-α in these cells (18Chen P. Mayne M. Power C. Nath A. J. Biol. Chem. 1997; 272: 22385-22388Abstract Full Text Full Text PDF PubMed Scopus (202) Google Scholar). Hence, to determine the effect of Tat on the production of cytokines IL-1β and IL-6, we treated THP-1 and U373 cells with Tat and measured IL-1β and IL-6 in the culture supernatants. Increasing levels of IL-1β were produced by THP-1 cells in a dose-dependent manner. Significant increases were noted with concentrations of 100 ng/ml Tat (Fig.2 A). To determine whether the induction of IL-1β occurred at the level of transcription or translation, we estimated IL-1β mRNA levels in THP-1 cells by RT-PCR. Tat induced IL-1β mRNA expression in a dose-dependent manner. The RT-PCR was much more sensitive and was able to detect IL-1β mRNA induction with 10 ng/ml Tat (Fig. 2 D). The U373 cells did not produce detectable levels of IL-1β in the culture supernatants, even with 1 μg/ml Tat. Since stimuli such as IL-1α and IL-2 result in production of cell associated IL-1β (23Dinarello C.A. Immunol. Lett. 1987; 16: 227-231Crossref PubMed Scopus (110) Google Scholar,24Numerof R.P. Kotik A.N. Dinarello C.A. Mier J.W. Cell Immunol. 1990; 130: 118-128Crossref PubMed Scopus (23) Google Scholar), we tested cell extracts for the presence of IL-1β but were still unable to detect any IL-1β protein (data not shown). To determine whether the block in IL-1β production was at the level of transcription or translation, we measured mRNA levels in Tat treated U373 cells. IL-1β mRNA levels in U373 cells were comparable with that of THP-1 cells (Fig. 2, D andE). Hence there was a translation block in the U373 cells. Significant amounts of IL-6 were produced in the culture supernatants of THP-1 cells and the U373 cells (Fig. 2, B andC). Comparatively, however, the U373 cells produced nearly 20-fold more IL-6 than the THP-1 cells at both 100 ng/ml and 1 μg/ml concentrations of Tat. IL-6 mRNA production paralleled the production of IL-6 protein in U373 cells (Fig. 2, C andF) and THP-1 cells (data not shown). We next conducted experiments to determine whether a transient exposure to Tat would be sufficient to induce cytokine production in U373 and THP-1 cells. A 5-min incubation was insufficient for inducing TNF-α or IL-1β in THP-1 cells, but was sufficient to induce IL-6 production in U373 cells at 180 min post Tat exposure (Fig.3). Following a 30- or 60-min exposure to Tat, all three cytokines could be induced. A 60-min exposure led to higher levels and earlier release of cytokines (Fig. 3). We used highly purified Tat protein in all our experiments and have previously shown the specificity of Tat action (18Chen P. Mayne M. Power C. Nath A. J. Biol. Chem. 1997; 272: 22385-22388Abstract Full Text Full Text PDF PubMed Scopus (202) Google Scholar, 25Magnuson D.S. Knudsen B.E. Geiger J.D. Brownstone R.M. Nath A. Ann. Neurol. 1995; 37: 373-380Crossref PubMed Scopus (256) Google Scholar). However, to further determine whether there were any contaminating substances that may result in IL-1β or IL-6 production, we immunoadsorbed Tat and used the remaining solution for treating the cells. The cell extracts were analyzed for IL-1β and IL-6 mRNA levels, since this was a much more sensitive technique for detection of Tat effects as compared with cytokine detection in culture supernatants. A complete block in IL-1β and IL-6 mRNA production was noted as shown in the U373 cells (Fig. 4), demonstrating that our Tat preparations are devoid of other bioactive substances. Previous studies have shown that Tat induces NFκB activation (26Conant K. Ma M. Nath A. Major E.O. J. Virol. 1996; 70: 1384-1389Crossref PubMed Google Scholar) and that Tat-induced TNF-α production is NFκB-dependent (18Chen P. Mayne M. Power C. Nath A. J. Biol. Chem. 1997; 272: 22385-22388Abstract Full Text Full Text PDF PubMed Scopus (202) Google Scholar). Hence, we pretreated the cells with TLCK, an inhibitor of NFκB activation followed by incubation with Tat. A complete block in IL-1β and IL-6 production was noted in the U373 cells (Fig.5, A and B) and the THP-1 cells (data not shown). We examined the role of extracellular divalent cations including calcium in Tat-induced cytokine production. Neither EGTA nor BAPTA was able to block cytokine production. Fig.5 C shows the effect on IL-1β production in U373 cells. A similar lack of response was seen for IL-6 production in U373 cells and IL-1β and IL-6 production in THP-1 cells (data not shown). Our studies show that cytokine expression in monocytes and astrocytes are differentially regulated by Tat. While monocytes could be induced to produce all three cytokines, i.e. IL-1β, IL-6, and TNF-α, astrocytes produced only IL-6. The levels of IL-6 produced by astrocytic cells were nearly 20-fold greater than those produced by monocytic cells. The astrocytic cells did not produce measurable amounts of IL-1β, even though mRNA for IL-1β could be induced. Similarly, we have shown previously that Tat could induce only small amounts of TNF-α in the astrocytic cells (18Chen P. Mayne M. Power C. Nath A. J. Biol. Chem. 1997; 272: 22385-22388Abstract Full Text Full Text PDF PubMed Scopus (202) Google Scholar). Furthermore, we were unable to inhibit the production of IL-6 with antisera to TNF-α in astrocytes or monocytes. This is an interesting observation, since IL-1β and TNF-α have been shown to induce IL-6 gene expression in astrocytes (27Norris J.G. Tang L. Sparacio S.M. Benveniste E.N. J. Immunol. 1994; 152: 841-850PubMed Google Scholar). This suggests that the effect of Tat on IL-6 production is specific. Within the brain, IL-1β is primarily produced by activated microglia (brain macrophages) (28Lee S.C. Dickson D.W. Liu W. Brosnan C.F. J. Neuroimmunol. 1993; 46: 19-24Abstract Full Text PDF PubMed Scopus (344) Google Scholar). HIV-infected macrophages also release high levels of IL-1β (29Genis P. Jett M. Bernton E.W. Boyle T. Gelbard H.A. Dzenko K. Keane R.W. Resnick L. Mizrachi Y. Volsky D.J. Epstein L. Gendelman H. J. Exp. Med. 1992; 176: 1703-1718Crossref PubMed Scopus (497) Google Scholar). Our studies show that Tat protein may, at least in part, contribute to the elevation of IL-1β levels in the brain of patients with HIV dementia. Tat-induced IL-1β is independent of TNF-α production. The increase in IL-1β may induce astrocytosis (30da Cunha A. Jefferson J.J. Tyor W.R. Glass J.D. Jaznnotta F.S. Vitkovic L. Brain Res. 1993; 631: 39-45Crossref PubMed Scopus (79) Google Scholar), promote HIV-1 replication (31Poli G. Fauci A.S. Pathobiology. 1992; 60: 246-251Crossref PubMed Scopus (68) Google Scholar), and induce other cytokines such as TNF-α (28Lee S.C. Dickson D.W. Liu W. Brosnan C.F. J. Neuroimmunol. 1993; 46: 19-24Abstract Full Text PDF PubMed Scopus (344) Google Scholar), resulting in further brain injury. Tat-treated astrocytic cells not only produced large amounts of IL-6, but the elevated levels were present for prolonged periods. Several studies have shown that astrocytes are an important source of IL-6 (32Benveniste E.N. Sparacio S.M. Norris J.G. Grenett H.E. Fuller G.M. J. Neuroimmunol. 1990; 30: 201-212Abstract Full Text PDF PubMed Scopus (295) Google Scholar). IL-6 has prominent effects on the brain, which include activation of the hypothalamic pituitary-adrenal axis, decreased appetite, and neuronal growth (33Akira S. Kishimoto T. Immunol. Rev. 1992; 313: 47-50Google Scholar). Furthermore, IL-6 has been implicated in neuronal degeneration. Transgenic mice with IL-6 develop severe neurologic disease accompanied with neurodegeneration and astrocytosis (34Campbell I.L. Abraham C.R. Masliah E. Kemper P. Inglis J.D. Oldstone M.B. Mucke L. Proc. Natl. Acad. Sci. U. S. A. 1993; 90: 10061-10065Crossref PubMed Scopus (882) Google Scholar). IL-6 has also been implicated in pathogenesis of neuronal injury in Alzheimer's disease (35Hull M. Fiebich B.L. Lieb K. Strauss S. Berger S.S. Volk B. Bauer J. Neurobiol. Aging. 1996; 17: 795-800Crossref PubMed Scopus (83) Google Scholar). Tat has been shown to induce changes in intracellular calcium in neurons through an influx of extracellular calcium (36Haughey N.J. Nath A. Holden C.P. Geiger J.D. J. Neurovirol. 1998; 4: 353Google Scholar). We hence examined the role of extracellular calcium in Tat-induced cytokine production. Removal of extracellular calcium had no effect on cytokine production. These observations are interesting since a recent study showed that calcium channel antagonists do not significantly alter the course of HIV dementia (37Navia B.A. Dafni U. Simpson D. Tucker T. Singer E. McArthur J.C. Yiannoutsos C. Zaborski L. Lipton S.A. Neurology. 1998; 51: 221-228Crossref PubMed Scopus (97) Google Scholar). Previous studies have shown NFκB activation in the brains of patients with HIV infection (38Dollard S.C. James H.J. Sharer L.R. Epstein L.G. Gelbard H.A. Dewhurst S. Neuropathol. Appl. Neurobiol. 1995; 21: 518-528Crossref PubMed Scopus (38) Google Scholar). Further Tat induces NFκB activation in glial cells (26Conant K. Ma M. Nath A. Major E.O. J. Virol. 1996; 70: 1384-1389Crossref PubMed Google Scholar). We now show that Tat-induced cytokine production is likely NFκB-dependent. Interestingly, the same cytokines have also been shown to activate NFκB itself (39Lowenthal J.W. Ballard D.W. Bohnlein E. Greene W.C. Proc. Natl. Acad. Sci. U. S. A. 1989; 86: 2331-2335Crossref PubMed Scopus (157) Google Scholar). Thus cytokine production once initiated by Tat could result in a positive feedback loop between NFκB and cytokine production. This process may therefore lead to an amplification of cytokine production without requiring the continued presence of Tat. Importantly, in this study we show that exposure to Tat for even a few minutes is sufficient to induce cytokine production in monocytes and astrocytes for prolonged periods of time. These findings are consistent with our previous observations that, following a single intraventricular injection of Tat in rats, progressive glial activation and macrophage infiltration could be seen for several days, even though Tat itself could not be detected in the brain after a few hours (12Jones M. Olafson K. Del Bigio M.R. Peeling J. Nath A. J. Neuropathol. Exp. Neurol. 1998; 57: 563-570Crossref PubMed Scopus (143) Google Scholar). Furthermore, an exposure of Tat in the order of only milliseconds is sufficient to induce prolonged depolarization in neurons (25Magnuson D.S. Knudsen B.E. Geiger J.D. Brownstone R.M. Nath A. Ann. Neurol. 1995; 37: 373-380Crossref PubMed Scopus (256) Google Scholar, 40Cheng J. Nath A. Knudsen B. Hochman S. Geiger J.D. Ma M. Magnuson D.S.K. Neuroscience. 1998; 82: 97-106Crossref PubMed Scopus (131) Google Scholar). Together, these studies suggest that a transient exposure to HIV-Tat protein results in a cascade of events leading to glial cell activation and neuronal degeneration. We thus propose that a “hit and run” phenomenon may be operative in neuropathogenesis of HIV infection, which may also explain why cross-sectional measurements of viral load in the brain at autopsy do not always correlate with neuronal degeneration and dementia. We thank Tanis Benidictson and Carol Anderson for technical assistance and Jonathan Geiger and Melina Jones for helpful comments." @default.
• W2010358244 created "2016-06-24" @default.
• W2010358244 creator A5000097172 @default.
• W2010358244 creator A5016574445 @default.
• W2010358244 creator A5024332094 @default.
• W2010358244 creator A5068826007 @default.
• W2010358244 creator A5089300901 @default.
• W2010358244 date "1999-06-01" @default.
• W2010358244 modified "2023-09-26" @default.
• W2010358244 title "Transient Exposure to HIV-1 Tat Protein Results in Cytokine Production in Macrophages and Astrocytes" @default.
• W2010358244 cites W1524845305 @default.
• W2010358244 cites W1817103017 @default.
• W2010358244 cites W1870780415 @default.
• W2010358244 cites W1905320291 @default.
• W2010358244 cites W1965149830 @default.
• W2010358244 cites W1966700067 @default.
• W2010358244 cites W1971653058 @default.
• W2010358244 cites W1974521776 @default.
• W2010358244 cites W1974708990 @default.
• W2010358244 cites W1975803523 @default.
• W2010358244 cites W1987871624 @default.
• W2010358244 cites W1993201898 @default.
• W2010358244 cites W1997653290 @default.
• W2010358244 cites W2005807968 @default.
• W2010358244 cites W2006733828 @default.
• W2010358244 cites W2007500354 @default.
• W2010358244 cites W2014964914 @default.
• W2010358244 cites W2027580727 @default.
• W2010358244 cites W2031925670 @default.
• W2010358244 cites W2039683993 @default.
• W2010358244 cites W2042572340 @default.
• W2010358244 cites W2058066653 @default.
• W2010358244 cites W2062137913 @default.
• W2010358244 cites W2062200627 @default.
• W2010358244 cites W2065426442 @default.
• W2010358244 cites W2070126126 @default.
• W2010358244 cites W2071009892 @default.
• W2010358244 cites W2077012020 @default.
• W2010358244 cites W2080742766 @default.
• W2010358244 cites W2085981166 @default.
• W2010358244 cites W2089232076 @default.
• W2010358244 cites W2089421056 @default.
• W2010358244 cites W2091734110 @default.
• W2010358244 cites W2097972613 @default.
• W2010358244 cites W2117271577 @default.
• W2010358244 cites W2120658132 @default.
• W2010358244 cites W4230229878 @default.
• W2010358244 cites W4251811430 @default.
• W2010358244 doi "https://doi.org/10.1074/jbc.274.24.17098" @default.
• W2010358244 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10358063" @default.
• W2010358244 hasPublicationYear "1999" @default.
• W2010358244 type Work @default.
• W2010358244 sameAs 2010358244 @default.
• W2010358244 citedByCount "331" @default.
• W2010358244 countsByYear W20103582442012 @default.
• W2010358244 countsByYear W20103582442013 @default.
• W2010358244 countsByYear W20103582442014 @default.
• W2010358244 countsByYear W20103582442015 @default.
• W2010358244 countsByYear W20103582442016 @default.
• W2010358244 countsByYear W20103582442017 @default.
• W2010358244 countsByYear W20103582442018 @default.
• W2010358244 countsByYear W20103582442019 @default.
• W2010358244 countsByYear W20103582442020 @default.
• W2010358244 countsByYear W20103582442021 @default.
• W2010358244 countsByYear W20103582442022 @default.
• W2010358244 countsByYear W20103582442023 @default.
• W2010358244 crossrefType "journal-article" @default.
• W2010358244 hasAuthorship W2010358244A5000097172 @default.
• W2010358244 hasAuthorship W2010358244A5016574445 @default.
• W2010358244 hasAuthorship W2010358244A5024332094 @default.
• W2010358244 hasAuthorship W2010358244A5068826007 @default.
• W2010358244 hasAuthorship W2010358244A5089300901 @default.
• W2010358244 hasBestOaLocation W20103582441 @default.
• W2010358244 hasConcept C111919701 @default.
• W2010358244 hasConcept C159047783 @default.
• W2010358244 hasConcept C185592680 @default.
• W2010358244 hasConcept C203014093 @default.
• W2010358244 hasConcept C2778690821 @default.
• W2010358244 hasConcept C2780799671 @default.
• W2010358244 hasConcept C3013748606 @default.
• W2010358244 hasConcept C41008148 @default.
• W2010358244 hasConcept C86803240 @default.
• W2010358244 hasConcept C95444343 @default.
• W2010358244 hasConceptScore W2010358244C111919701 @default.
• W2010358244 hasConceptScore W2010358244C159047783 @default.
• W2010358244 hasConceptScore W2010358244C185592680 @default.
• W2010358244 hasConceptScore W2010358244C203014093 @default.
• W2010358244 hasConceptScore W2010358244C2778690821 @default.
• W2010358244 hasConceptScore W2010358244C2780799671 @default.
• W2010358244 hasConceptScore W2010358244C3013748606 @default.
• W2010358244 hasConceptScore W2010358244C41008148 @default.
• W2010358244 hasConceptScore W2010358244C86803240 @default.
• W2010358244 hasConceptScore W2010358244C95444343 @default.
• W2010358244 hasIssue "24" @default.
• W2010358244 hasLocation W20103582441 @default.
• W2010358244 hasOpenAccess W2010358244 @default.
• W2010358244 hasPrimaryLocation W20103582441 @default.
• W2010358244 hasRelatedWork W185296467 @default.

• next